Zogenix

Developing drug delivery systems for treatment of CNS diseases

placeEmeryville, California, United States calendar_todayFounded 2006 groups159 employees language zogenix.com

Registered entities

Innovation

26 patent families (16 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 2,053 times.

YearFilings
201311
201415
20159
20169
20176
20181
20191
20201
20211
20222
20231
20241

Investor mix

13 investors on record; lead investors include Domain Associates, Scale Venture Partners, Life Science Angels, Blackstone; 3 have since exited.

Investor typeCountShare
Venture capital538%
Private equity538%
Angel & family office18%
Bank & private debt18%
Other / undisclosed18%
Coming soon